$PETS
PETMED EXPRESS INC

2021 Q3 Form 10-Q Financial Statement

#000143774921024890 Filed on November 02, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2020 Q3
Revenue $67.39M $75.44M
YoY Change -10.67% 7.86%
Cost Of Revenue $48.21M $52.42M
YoY Change -8.02% 4.97%
Gross Profit $19.17M $23.02M
YoY Change -16.7% 15.08%
Gross Profit Margin 28.45% 30.51%
Selling, General & Admin $10.39M $11.94M
YoY Change -12.96% 7.96%
% of Gross Profit 54.2% 51.87%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $694.0K $607.0K
YoY Change 14.33% 6.12%
% of Gross Profit 3.62% 2.64%
Operating Expenses $11.09M $12.55M
YoY Change -11.64% 7.88%
Operating Profit $8.087M $10.47M
YoY Change -22.77% 25.09%
Interest Expense $74.00K $70.00K
YoY Change 5.71% -84.78%
% of Operating Profit 0.92% 0.67%
Other Income/Expense, Net $244.0K $404.0K
YoY Change -39.6% -47.05%
Pretax Income $8.331M $10.88M
YoY Change -23.39% 19.06%
Income Tax $2.000M $2.500M
% Of Pretax Income 24.01% 22.99%
Net Earnings $6.349M $8.412M
YoY Change -24.52% 26.21%
Net Earnings / Revenue 9.42% 11.15%
Basic Earnings Per Share $0.31 $0.42
Diluted Earnings Per Share $0.31 $0.42
COMMON SHARES
Basic Shares Outstanding 20.18M 20.06M
Diluted Shares Outstanding 20.57M 20.15M

Balance Sheet

Concept 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $106.6M $106.3M
YoY Change 0.25% 12.01%
Cash & Equivalents $106.6M $106.3M
Short-Term Investments
Other Short-Term Assets $5.296M $2.600M
YoY Change 103.69% -7.14%
Inventory $19.73M $21.50M
Prepaid Expenses
Receivables $1.854M $2.212M
Other Receivables $0.00 $0.00
Total Short-Term Assets $133.4M $132.6M
YoY Change 0.62% 12.14%
LONG-TERM ASSETS
Property, Plant & Equipment $25.08M $25.47M
YoY Change -1.52% -3.57%
Goodwill
YoY Change
Intangibles $860.0K $860.0K
YoY Change 0.0% 0.0%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $25.94M $26.33M
YoY Change -1.47% -3.46%
TOTAL ASSETS
Total Short-Term Assets $133.4M $132.6M
Total Long-Term Assets $25.94M $26.33M
Total Assets $159.4M $158.9M
YoY Change 0.27% 9.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.18M $16.06M
YoY Change -30.36% 5.96%
Accrued Expenses $5.089M $4.500M
YoY Change 13.09% 55.17%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $16.27M $21.16M
YoY Change -23.11% 14.07%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $16.27M $21.16M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $17.90M $22.54M
YoY Change -20.59% 13.01%
SHAREHOLDERS EQUITY
Retained Earnings $132.7M $131.1M
YoY Change 1.28% 6.37%
Common Stock $21.00K $20.00K
YoY Change 5.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $141.5M $136.4M
YoY Change
Total Liabilities & Shareholders Equity $159.4M $158.9M
YoY Change 0.27% 9.22%

Cashflow Statement

Concept 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income $6.349M $8.412M
YoY Change -24.52% 26.21%
Depreciation, Depletion And Amortization $694.0K $607.0K
YoY Change 14.33% 6.12%
Cash From Operating Activities $1.497M $26.39M
YoY Change -94.33% 52.99%
INVESTING ACTIVITIES
Capital Expenditures -$495.0K -$1.040M
YoY Change -52.4% 352.17%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$495.0K -$1.040M
YoY Change -52.4% 352.17%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -6.226M -5.820M
YoY Change 6.98% 5.24%
NET CHANGE
Cash From Operating Activities 1.497M 26.39M
Cash From Investing Activities -495.0K -1.040M
Cash From Financing Activities -6.226M -5.820M
Net Change In Cash -5.224M 19.53M
YoY Change -126.75% 69.97%
FREE CASH FLOW
Cash From Operating Activities $1.497M $26.39M
Capital Expenditures -$495.0K -$1.040M
Free Cash Flow $1.992M $27.43M
YoY Change -92.74% 56.92%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
20942929
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
28000 USD
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
39000 USD
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
3000
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
3000
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
3000
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
3000
CY2021Q3 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
4
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
4
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20943000
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20943000
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20269000
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20269000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
115219
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
25136
us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
0
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
106562000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
118718000 USD
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1854000 USD
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2587000 USD
CY2021Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
19733000 USD
CY2021Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
34420000 USD
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4397000 USD
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4503000 USD
CY2021Q3 us-gaap Prepaid Taxes
PrepaidTaxes
899000 USD
CY2021Q1 us-gaap Prepaid Taxes
PrepaidTaxes
959000 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
133445000 USD
CY2021Q1 us-gaap Assets Current
AssetsCurrent
161187000 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25081000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25450000 USD
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
860000 USD
CY2021Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
860000 USD
CY2021Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
25941000 USD
CY2021Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
26310000 USD
CY2021Q3 us-gaap Assets
Assets
159386000 USD
CY2021Q1 us-gaap Assets
Assets
187497000 USD
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
11183000 USD
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
39548000 USD
CY2021Q3 pets Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
5089000 USD
CY2021Q1 pets Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
5387000 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
16272000 USD
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
44935000 USD
CY2021Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1627000 USD
CY2021Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1281000 USD
CY2021Q3 us-gaap Liabilities
Liabilities
17899000 USD
CY2021Q1 us-gaap Liabilities
Liabilities
46216000 USD
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
9000 USD
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
9000 USD
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
21000 USD
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
20000 USD
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8711000 USD
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7111000 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
132746000 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
134141000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
141487000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
141281000 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
159386000 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
187497000 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
67386000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
75436000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
146698000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
171640000 USD
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
48212000 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
52418000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
105744000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
121837000 USD
CY2021Q3 us-gaap Gross Profit
GrossProfit
19174000 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
23018000 USD
us-gaap Gross Profit
GrossProfit
40954000 USD
us-gaap Gross Profit
GrossProfit
49803000 USD
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6958000 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6809000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14999000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14563000 USD
CY2021Q3 us-gaap Advertising Expense
AdvertisingExpense
3435000 USD
CY2020Q3 us-gaap Advertising Expense
AdvertisingExpense
5131000 USD
us-gaap Advertising Expense
AdvertisingExpense
11108000 USD
us-gaap Advertising Expense
AdvertisingExpense
14164000 USD
CY2021Q3 us-gaap Depreciation
Depreciation
694000 USD
CY2020Q3 us-gaap Depreciation
Depreciation
607000 USD
us-gaap Depreciation
Depreciation
1341000 USD
us-gaap Depreciation
Depreciation
1169000 USD
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
11087000 USD
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
12547000 USD
us-gaap Operating Expenses
OperatingExpenses
27448000 USD
us-gaap Operating Expenses
OperatingExpenses
29896000 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
8087000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
10471000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
13506000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
19907000 USD
CY2021Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
74000 USD
CY2020Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
66000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
159000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
156000 USD
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
170000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
338000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
454000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
593000 USD
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
244000 USD
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
404000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
613000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
749000 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
8331000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
10875000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
14119000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
20656000 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1982000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2463000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3342000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4476000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
6349000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
8412000 USD
us-gaap Net Income Loss
NetIncomeLoss
10777000 USD
us-gaap Net Income Loss
NetIncomeLoss
16180000 USD
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.42
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.53
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.81
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.42
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.53
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.81
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20178000
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20063000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20144000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20024000
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20568000
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20154000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20384000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20098000
CY2021Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.30
CY2020Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.28
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.60
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.56
us-gaap Net Income Loss
NetIncomeLoss
10777000 USD
us-gaap Net Income Loss
NetIncomeLoss
16180000 USD
us-gaap Depreciation
Depreciation
1341000 USD
us-gaap Depreciation
Depreciation
1169000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1600000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1513000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
346000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
408000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
58000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
61000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-675000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1570000 USD
us-gaap Increase Decrease In Finished Goods And Work In Process Inventories
IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories
-14687000 USD
us-gaap Increase Decrease In Finished Goods And Work In Process Inventories
IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories
3567000 USD
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
-60000 USD
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
-0 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-106000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-916000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-28365000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3600000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-210000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
391000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
147000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1075000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
15188000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
972000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1193000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-972000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1193000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
12259000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
11413000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-12259000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-11413000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-12156000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2582000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
118718000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
103762000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
106562000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
106344000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
2935000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
4206000 USD
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
110000 USD
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
126000 USD
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Use of Estimates</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:18pt;">The preparation of Condensed Consolidated Financial Statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Condensed Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
67386000 USD
CY2021Q3 pets Revenue From Contract With Customer Percentage
RevenueFromContractWithCustomerPercentage
1.000 pure
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
75436000 USD
CY2020Q3 pets Revenue From Contract With Customer Percentage
RevenueFromContractWithCustomerPercentage
1.000 pure
CY2021Q3 pets Revenue From Contract With Customer Variance
RevenueFromContractWithCustomerVariance
-8050000 USD
CY2021Q3 pets Revenue From Contract With Customer Variance Percentage
RevenueFromContractWithCustomerVariancePercentage
-0.107 pure
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
67386000 USD
CY2021Q3 pets Revenue From Contract With Customer Percentage
RevenueFromContractWithCustomerPercentage
1.000 pure
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
75436000 USD
CY2020Q3 pets Revenue From Contract With Customer Percentage
RevenueFromContractWithCustomerPercentage
1.000 pure
CY2021Q3 pets Revenue From Contract With Customer Variance
RevenueFromContractWithCustomerVariance
-8050000 USD
CY2021Q3 pets Revenue From Contract With Customer Variance Percentage
RevenueFromContractWithCustomerVariancePercentage
-0.107 pure
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
146698000 USD
pets Revenue From Contract With Customer Percentage
RevenueFromContractWithCustomerPercentage
1.000 pure
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
171640000 USD
pets Revenue From Contract With Customer Percentage
RevenueFromContractWithCustomerPercentage
1.000 pure
pets Revenue From Contract With Customer Variance
RevenueFromContractWithCustomerVariance
-24942000 USD
pets Revenue From Contract With Customer Variance Percentage
RevenueFromContractWithCustomerVariancePercentage
-0.145 pure
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
146698000 USD
pets Revenue From Contract With Customer Percentage
RevenueFromContractWithCustomerPercentage
1.000 pure
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
171640000 USD
pets Revenue From Contract With Customer Percentage
RevenueFromContractWithCustomerPercentage
1.000 pure
pets Revenue From Contract With Customer Variance
RevenueFromContractWithCustomerVariance
-24942000 USD
pets Revenue From Contract With Customer Variance Percentage
RevenueFromContractWithCustomerVariancePercentage
-0.145 pure
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
6349000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
8412000 USD
us-gaap Net Income Loss
NetIncomeLoss
10777000 USD
us-gaap Net Income Loss
NetIncomeLoss
16180000 USD
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20178000
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20063000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20144000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20024000
CY2021Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
380000
CY2020Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
81000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
230000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
64000
CY2021Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
10000
CY2020Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
10000
us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
10000
us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
10000
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20568000
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20154000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20384000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20098000
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.42
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.53
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.81
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.42
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.53
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.81
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
115219
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
25136
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
106600000 USD
us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
0
CY2021Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
28700000 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000000.0 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2500000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3300000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4500000 USD
CY2021Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.238 pure
CY2020Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.226 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.237 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.217 pure
CY2020Q2 us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
285000 USD

Files In Submission

Name View Source Status
0001437749-21-024890-index-headers.html Edgar Link pending
0001437749-21-024890-index.html Edgar Link pending
0001437749-21-024890.txt Edgar Link pending
0001437749-21-024890-xbrl.zip Edgar Link pending
ex_299334.htm Edgar Link pending
ex_299335.htm Edgar Link pending
ex_299336.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pets-20210930.xsd Edgar Link pending
pets-20210930_cal.xml Edgar Link unprocessable
pets-20210930_def.xml Edgar Link unprocessable
pets-20210930_lab.xml Edgar Link unprocessable
pets-20210930_pre.xml Edgar Link unprocessable
pets20210930_10q.htm Edgar Link pending
pets20210930_10q_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending